Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Gene Panel Market Research Report Information By Technique (Amplicon Based Approach and Hybridization Based Approach) By Design (Predesigned Gene Panel and Customized Gene Panel) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/LS/4642-CR | 220 Pages | Author: Rahul Gotadki| January 2020

Global Gene Panel Market Overview


The Gene Panel Market Size valued at USD 1.1 Billion in 2022. The Gene Panel market industry is projected to grow from USD 1.25 Billion in 2023 to USD 3.49 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 13.72% during the forecast period (2023 - 2032). The increased number of cases of chronic diseases and growing investment by the government and the major market players are the key market drivers enhancing the growth of market.Gene Panel Market


Source The Secondary Research, Primary Research, MRFR Database, and Analyst Review


Gene Panel Market Trends



  • Growing cases of the chronic diseases are driving the market growth


Market CAGR for gene panels is being driven by the rising cases of chronic diseases. The growing burden of chronic diseases that are associated with genes like heart attack, stroke, cancer, arthritis, and others is anticipated to boost the market growth. Further, the increasing number of product approval and launches is foreseen to boost the  gene panel market throughout the forecast period. The rising variety in the cases of cancers in females and males both and the benefits offered by the gene panel market.


A gene panel is a test that helps to analyze multiple genes at the same time for cancer-associated mutations. This test has the ability to examine a various genes that helps in providing information related to cancer and also offers a secure diagnostic that assists in preventing cancer from spreading. The growing number of cancer cases of different types, including breast cancer, cancer of the ovaries, fallopian tubes, and prostate cancer in men, and rising frequencies of chronic diseases throughout the world are the main factor boosting the gene panel market. Further, a growing number of initiatives taken by different companies worldwide and other benefits of gene panels are the prime reasons favoring the growth of the gene panel market. As per the Genetic and Rare Disease Information Center, there are around 7,000 diagnosed genetic conditions, and the list is continuously increasing. Several gene panels are fabricated to detect genetic disorders at birth so that effective therapeutic steps and prognoses can be taken as early as possible.


During the forecast period, huge investment is anticipated by the market players and the government to be done, and a rising pool of patients offers growth opportunities in the coming years. The advancement in technology and the rising need for prenatal diagnosis are other factors boosting the growth of the market. Thus, driving the Gene Panel market revenue.


However, the strict regulations and policies by the government for the pharmaceutical companies and protection issues about genetic data are the prime challenge experienced by the gene panel market and restraining the market growth. Further, the inability of next-generation sequencing (NGS) gene panels is detecting some allelic mutations, thus impacting the market growth.


Gene Panel Market Segment Insights


Gene Panel Technique Insights


The Gene Panel market segmentation, based on technique, includes Amplicon Based Approach and Hybridization Based Approach. The amplicon-based approach segment dominates the market, accounting for the largest market revenue as it is the popular target-based next-generation sequencing method that analyzes genetic discrepancy in a specific genome region. It is utilized for genotyping through sequencing, locating an inherited SNP, validation of CRISP, and detection of indels. Further, the hybridization approach is the best in regard to complexity and uniformity, which is advantageous when sequencing a large number of genes. It is often utilized for multigene panels in different clinical applications owing to its reliability and reproducibility.


Gene Panel Design Insights


The Gene Panel market segmentation, based on design, includes Predesigned Gene Panel and Customized Gene Panels. The predesigned gene panel segment dominated the market as humans are yet at the developing stage of understanding the genetic predisposition to any disorder; it is always most relevant that the predesigned gene panels are utilized for consumer genetic testing in order to yield comprehensive analysis. Further, the customized gene panel segment is expected to witness steady growth as it is utilized for the diagnosis of rare disorders and several research purposes where a deep understanding of a particular rare gene disorder is important.


Figure 1 Gene Panel Market, by Design, 2022 & 2032 (USD Billion)Gene Panel Market, by Design, 2022 & 2032


Source The Secondary Research, Primary Research, MRFR Database, and Analyst Review


Gene Panel Regional Insights


By region, the study gives market insights into the North America, Europe, Asia-Pacific, and the Rest of the World. The North American Gene Panel market area dominates the market due to the extensive research that are carried out in different research institutes collaboratively sponsored by academic research institutes, National Cancer Institutes, and pharmaceutical giants throughout the region. The US is the largest contributor to the growth of the gene panel market in the North American region.


Further, the prime countries studied in the market report are the US, Canada, France, German, the UK, Italy, Spain, Japan, India, China, Australia, South Korea, and Brazil.


Figure 2 GENE PANEL MARKET SHARE BY REGION 2022 (USD Billion)GENE PANEL MARKET SHARE BY REGION 2022


Source The Secondary Research, Primary Research, MRFR Database, and Analyst Review


Europe Gene Panel market accounts for the second-largest market revenue due to the rise in the number of cases of cancer and increasing investment in research and development made by various organizations. Further, the German Gene Panel market held the largest market share, and the UK Gene Panel market was the rapid-growing market in European region.


The Asia-Pacific Gene Panel Market is expected to grow at the rapid CAGR from 2023 to 2032. This is due to the rising expenditure on healthcare facilities by the government and the presence of highly populous countries in this region. Moreover, China’s Gene Panel market held the largest market share, and the Indian Gene Panel market was the rapid-growing market in Asia-Pacific region.


Gene Panel Key Market Players & Competitive Insights


Leading market players are investing hugely in research and development in order to expand their product lines, which will help the Gene Panel market grow even more. Market players are also undertaking a variety of strategic activities to spread their footprint, with important market developments including new product launches, higher investments, contractual agreements, mergers and acquisitions, and collaboration with other organizations. To spread and survive in a more competitive and rising market climate, the Gene Panel industry must offer cost-effective items.


Manufacturing locally to minimize the operational costs is one of the key business tactics used by the manufacturers in the Gene Panel industry to benefit clients and  the market sector. In recent years, the Gene Panel industry has offered some of the most significant advantages to the biotechnology industry. Major players in the Gene Panel market, including Eurofins Genomics, Illumina Inc, Gencove, Centogene NV, Myriad Genetic Laboratories Inc., Agilent Technologies, Thermo Fisher Scientific, Foundation Medicine Inc., Bio-Rad Laboratories Inc., Guardant Health Inc., others, are attempting to increase market demand by investing in research and development operations.


Gencove, a US-based biotechnology company founded in the year 2015, is the provider of information proposed to make genome sequencing technologies more accessible and analyzed. The company makes molecular and computational tools for enabling high-throughput and low-cost genome sequencing technologies for industries like agriculture and pharma, allowing the researchers to have access to genomic data. In January 2021, the company and BGI Americas Corporation, which is a subsidiary of BGI Genomics in the US, announced the extension of collaboration which was intended to combine sequencing assistance BGI using proprietary DNBSEQ sequencing technologies with the evaluation interface of Gencove in order to use high-capacity, cost-effective whole genome data for actionable tasks.


Illumina Inc is an American biotechnology company founded in the year 1998, headquartered in San Diego, California, serving more than 140 countries. The company develops, produces, and sells integrated systems for the interpretation of genetic variation and biological function, providing a line of services and products that serves the genotyping, sequencing, gene expression, and proteomics markets. The company sells a variety of high-throughput DNA sequencing systems, depending on technology developed by Solexa. In March 2022, the company launched the TruSight Oncology Comprehensive test in the European region, which can capably evaluate a total of 517 tumor genes throughout 30 types of cancer and biomarkers to be able to gain specific individual molecular profiles. The test evaluates peculiar genomic signatures like tumor mutational burden and microsatellite instability.


Key Companies in the Gene Panel market includes



  • Eurofins Genomics

  • Illumina Inc

  • Gencove

  • Centogene NV

  • Myriad Genetic Laboratories Inc.

  • Agilent Technologies

  • Thermo Fisher Scientific

  • Foundation Medicine Inc.

  • Bio-Rad Laboratories Inc.

  • Guardant Health Inc.


Gene Panel Industry Developments


March 2022 Eurofins Genomics encourages the mission of 'Our Future Health,' which is the largest ever health analysis program of the UK to assist genotype five million individuals in order to generate a diverse idea of the health of inhabitants in the UK. This is helpful data for diagnosis, prevention, and therapy of ailments.


June 2022 Centogene NV announced the expansion of its collaboration with Agios Pharmaceuticals Inc. in order to devise improved therapeutics for genetically confirmed infirmity by using PYRUKYND. This is the first-in-class, selective, small-molecule activator of the pyruvate kinase enzymes.


February 2021 Hydroxycut's novel creation, CUT Energy, a delectable clean energy drink, was released. This powerful mix was thencarefully formulated for regular energy drink consumers, the exercise enthusiasts, and dieters looking to lose weight.


Gene Panel Market Segmentation


Gene Panel Technique Outlook



  • Amplicon Based Approach

  • Hybridization Based Approach


Gene Panel Design Outlook



  • Predesigned Gene Panel

  • Customized Gene Panel


Gene Panel Regional Outlook



  • North America

    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Gene Panel Report Scope
Report Attribute/Metric Details
Market Size 2022 USD 1.1 Billion
Market Size 2023 USD 1.25 Billion
Market Size 2032 USD 3.49 Billion
Compound Annual Growth Rate (CAGR) 13.72% (2023-2032)
Base Year 2022
Market Forecast Period 2023-2032
Historical Data 2018- 2022
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, The Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Technique, Design, and Region
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The US, Canada, German, France, UK, Italy, Spain, Japan, China, India, Australia, South Korea, and Brazil
Key Companies Profiled Eurofins Genomics, Illumina Inc, Gencove, Centogene NV, Myriad Genetic Laboratories Inc., Agilent Technologies, Thermo Fisher Scientific, Foundation Medicine Inc., Bio-Rad Laboratories Inc., Guardant Health Inc. 
Key Market Opportunities Technological advancement in the field of biotechnology.
Key Market Dynamics Increased cases of chronic diseases and rising investments by government and market players.


Frequently Asked Questions (FAQ) :

The Gene Panel market size valued at USD 1.1 Billion in 2022.

The market is projected to raise at a CAGR of 13.72% throughout the forecast period, 2023-2032.

North America had the largest share of the market

The key players in the market are Eurofins Genomics, Illumina Inc, Gencove, Centogene NV, Myriad Genetic Laboratories Inc., Agilent Technologies, Thermo Fisher Scientific, Foundation Medicine Inc., Bio-Rad Laboratories Inc., Guardant Health Inc.

The Amplicon-Based Approach category dominated the market in 2022.

The Predesigned Gene Panel had the largest share in the market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization